Loang, Janice .
HRN: 20-67-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/01/2025
03/08/2025
IV
4.5g
Q8h
T/c SLE In Flare
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes